Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

C-reactive protein – more than a heart disease marker

27.01.2004


C-reactive protein, already accepted as indicating a risk of heart disease, also participates in the process of atherosclerosis that narrows heart arteries, said a Baylor College of Medicine (BCM) researcher.



In a report that went online in the "rapid track" portion of the website of Circulation, the journal of the American Heart Association, today, Dr. Lawrence Chan, chief of the BCM division of diabetes, endocrinology and metabolism, and members of his laboratory said that when mice genetically prone to develop atherosclerosis also produced a human form of C-reactive protein, they developed larger lesions associated with the buildup of fatty plaque in the arteries than did those who did not produce the protein.

"Our study supports the use of C-reactive protein as a marker of risk for heart disease," said Chan. "Not only that, but it identifies at least one mechanism by which the protein contributes to the development of atherosclerosis." He said this is the first time these facts have been demonstrated in living animals.


Atherosclerosis is associated with deposits of fatty plaque in the walls of arteries. When this significantly narrows the heart’s arteries, patients face an increased risk of heart attack.

C-reactive protein is an indication that there is inflammation in the body. When its levels are high, physicians suspect that an individual’s risk of developing heart disease is equally elevated. Chan and his colleagues, including Dr. Antoni Paul, a postdoctoral fellow at BCM who did most of the laboratory analysis, identified high levels of an arterial wall cell surface protein called angiotensin type 1 receptor in the atherosclerotic deposits in the mice that expressed C-reactive protein. Mice that lacked C-reactive protein had lower levels of the receptor.

High levels of the receptor make cells more susceptible to inflammatory attack, said Chan. Some medications now used to treat heart disease block a form of angiotensin receptor and could be more effective in individuals with high levels of C-reactive protein, he said.

Further research will be needed to confirm that, he said.

Anissa Orr | EurekAlert!
Further information:
http://research.bcm.tmc.edu/

More articles from Health and Medicine:

nachricht Potential seen for tailoring treatment for acute myeloid leukemia
10.12.2018 | University of Washington Health Sciences/UW Medicine

nachricht UC San Diego researchers develop sensors to detect and measure cancer's ability to spread
06.12.2018 | University of California - San Diego

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Researchers develop method to transfer entire 2D circuits to any smooth surface

What if a sensor sensing a thing could be part of the thing itself? Rice University engineers believe they have a two-dimensional solution to do just that.

Rice engineers led by materials scientists Pulickel Ajayan and Jun Lou have developed a method to make atom-flat sensors that seamlessly integrate with devices...

Im Focus: Three components on one chip

Scientists at the University of Stuttgart and the Karlsruhe Institute of Technology (KIT) succeed in important further development on the way to quantum Computers.

Quantum computers one day should be able to solve certain computing problems much faster than a classical computer. One of the most promising approaches is...

Im Focus: Substitute for rare earth metal oxides

New Project SNAPSTER: Novel luminescent materials by encapsulating phosphorescent metal clusters with organic liquid crystals

Nowadays energy conversion in lighting and optoelectronic devices requires the use of rare earth oxides.

Im Focus: A bit of a stretch... material that thickens as it's pulled

Scientists have discovered the first synthetic material that becomes thicker - at the molecular level - as it is stretched.

Researchers led by Dr Devesh Mistry from the University of Leeds discovered a new non-porous material that has unique and inherent "auxetic" stretching...

Im Focus: The force of the vacuum

Scientists from the Theory Department of the Max Planck Institute for the Structure and Dynamics of Matter (MPSD) at the Center for Free-Electron Laser Science (CFEL) in Hamburg have shown through theoretical calculations and computer simulations that the force between electrons and lattice distortions in an atomically thin two-dimensional superconductor can be controlled with virtual photons. This could aid the development of new superconductors for energy-saving devices and many other technical applications.

The vacuum is not empty. It may sound like magic to laypeople but it has occupied physicists since the birth of quantum mechanics.

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

New Plastics Economy Investor Forum - Meeting Point for Innovations

10.12.2018 | Event News

EGU 2019 meeting: Media registration now open

06.12.2018 | Event News

Expert Panel on the Future of HPC in Engineering

03.12.2018 | Event News

 
Latest News

Proteins imaged in graphene liquid cell have higher radiation tolerance

10.12.2018 | Materials Sciences

New Plastics Economy Investor Forum - Meeting Point for Innovations

10.12.2018 | Event News

A new molecular player involved in T cell activation

07.12.2018 | Life Sciences

VideoLinks
Science & Research
Overview of more VideoLinks >>>